Filter
355
Filtered Results: 355
Text search:
Amstrong,
C.
Featured
Recommendations
37
New Publications
41
Language
Document type
No document type
130
Studies & Reports
116
Guidelines
56
Strategic & Response Plan
20
Manuals
15
Training Material
11
Fact sheets
5
Resource Platforms
1
Infographics
1
Countries / Regions
Global
34
Kenya
10
India
9
South Africa
6
Brazil
6
Latin America and the Carribbean
6
Russia
6
Tanzania
5
Western and Central Europe
5
Africa
5
Ethiopia
4
Uganda
4
Ukraine
4
Malawi
3
Mozambique
3
Middle East and North Africa
3
Sierra Leone
2
USA
2
Philippines
2
China
2
Colombia
2
East and Southern Africa
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Asia
2
Eastern Europe
2
Guinea
1
Burkina Faso
1
Liberia
1
Nigeria
1
Senegal
1
Guinea-Bissau
1
Cameroon
1
Zimbabwe
1
Turkey
1
Syria
1
Cambodia
1
Rwanda
1
Singapore
1
Central African Republic
1
Peru
1
El Salvador
1
Angola
1
Myanmar / Burma
1
Western Pacific Region
1
Italy
1
Laos
1
Vietnam
1
Authors & Publishers
Publication Years
Category
Countries
77
Clinical Guidelines
36
Public Health
29
Women & Child Health
18
Key Resources
12
Capacity Building
11
Pharmacy & Technologies
2
Toolboxes
HIV
49
COVID-19
37
Planetary Health
34
Mental Health
29
Disability
25
NCDs
21
Caregiver
20
TB
15
Global Health Education
9
Health Financing Toolbox
9
AMR
8
Pharmacy
6
Refugee
5
Social Ethics
5
Ebola
4
Conflict
4
Rapid Response
4
NTDs
4
Natural Hazards
2
Zika
1
Health Financing
1
The two-year impact report for the Access to COVID-19 Tools (ACT) Accelerator details impact, case studies and timelines of key milestones for the Diagnostics, Therapeutics and Vaccines pillars, as well as the Health Systems and Response Connector.
Whole-genome sequencing (WGS) provides a vast amount of information and the highest possible resolution for pathogen subtyping. The application of WGS for global surveillance can provide information on the early emergence and spread of AMR and further inform timely policy development on AMR control....
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
This twelfth version of the WHO living guideline now contains 19 recommendations. This latest update provides updated recommendations for remdesivir, addresses the use of combination therapy with corticosteroids, interleukin-6 (IL-6) receptor blockers and Janus kinase (JAK) inhibitors in patients wi...
The World Health Organization organized a Consultation of National Leprosy Programme managers, partners and affected persons to discuss the draft Global Leprosy Strategy, 2021--2030. This virtual event took place from 26 to 30 October 2020. It was attended by more than 450 stakeholders. Contribution...
BMJ 2019;365:l1807 doi: 10.1136/bmj.l1807 (Published 8 May 2019)
An Evidence-Based Treatment Guide for Clinicians
28 Dec 2020. The main objective of these guidelines is to provide tools for staff working in the field of immunization to support effective communication between health personnel and the general population, with the aim of strengthening, maintaining or recovering trust in vaccines and the immunizati...
31 Janaury 2021
SCORE for health data technical package. The first global assessment on the status and capacity of health information systems in 133 countries, covering 87% of the global population.
It identifies gaps and provides guidance for investment in areas that can have the greatest impact ...
3 February 2021
Vaccine- and vaccination-related crises require a communication response that is different from the communication strategies used to promote the benefits and importance of vaccines in general. This document presents the technical guidance needed to develop a communication plan that ...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
These guidelines group all recommendations on TB care and support in one document and are complemented by an operational handbook. The guidelines are to be used primarily by national TB programmes, or their equivalents in Ministries of Health, stakeholders and technical organizations working on...
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
A new brief published by the IFRC and Climate Centre today details the adverse impacts of climate change on human health and provides more detail on the second of four pillars of action in the Red Cross Red Crescent Movement ambitions on climate.
Background paper 9
The Independent Panel for Pandemic Preparedness and Response
May 2021
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G...
Available in Russian
A detailed overview is provided of the implementation of alcohol policies described in the 10 action areas of the European Action Plan to Reduce the Harmful Use of Alcohol 2012–2020 (EAPA), including the current status of implementation of the five action areas of the WHO-led...
Health in All Policies: A Guide for State and Local Governments was created by the Public Health Institute, the California Department of Public Health, and the American Public Health Association in response to growing interest in using collaborative approaches to improve population health by embedd...
